Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
3
×
fda
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
3
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
calcitonin gene-related peptide
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine research foundation
novartis
teva pharmaceutical
What
fda
won
3
×
approval
class
drug
drugs
migraine
new
amgen
arguments
august
big
bio
biotech
busy
candidates
commercialized
companies
competitors
days
decades
decisions
developed
devices
gets
head
legacy
make
medicines
meeting
neuro
news
nod
nods
opioid
oral
pain
past
potential
preventive
Language
unset
Current search:
national
×
" national top stories "
×
" eli lilly "
×
won
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines